Bright Uro has shared an update. The company announced that Hunterdon Health’s urologist Siobhan Hartigan, MD, FPMRS, FACS, is the first clinic in New Jersey to join the Glean community, adopting Bright Uro’s Glean system for urodynamic testing. Dr. Hartigan cited patient comfort, streamlined workflow, and preserved diagnostic quality as key advantages of the technology.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
For investors, this update signals continued commercial traction and geographic expansion of Bright Uro’s Glean platform into a new state and health system. Onboarding a specialist at Hunterdon Health supports validation of the technology in a real-world clinical setting and may encourage further adoption among urology and pelvic floor specialists, potentially expanding Bright Uro’s installed base and recurring usage. While the post does not disclose financial terms, growing clinical acceptance and network effects within the Glean community could enhance the company’s competitive position in urodynamic diagnostics and underpin future revenue growth if adoption scales across additional institutions and regions.

